| Well-controlled DM group | Poorly controlled DM group | Unadjusted | Multivariable adjusted* | Propensity-score matched | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | HR | 95% CI | P-value | |||
Early outcomes (< 30 days) | N = 516 | N = 752 |  |  |  |  |  |  | N = 904 (452 Pairs) | ||
 Early mortality | 1 (0.3%) | 1 (0.2%) | 0.638 | 0.040–10.232 |  > 0.999 |  |  |  | 0.248 | 0.028–2.231 | 0.374 |
 Bleeding requiring reoperation | 7 (1.4%) | 9 (1.2%) | 0.881 | 0.326–2.380 |  > 0.999 |  |  |  | 1.169 | 0.390–3.507 | > 0.999 |
 Graft related reoperation | 2 (0.4%) | 1 (0.1%) | 0.342 | 0.031–3.784 | 0.570 |  |  |  | 0.499 | 0.045–5.521 | > 0.999 |
 Myocardial infarction | 0 (0%) | 0 (0%) | NA | NA | NA |  |  |  | NA | NA | NA |
 Stroke | 3 (0.6%) | 8 (1.1%) | 1.839 | 0.485–6.964 | 0.540 |  |  |  | 2.354 | 0.605–9.162 | 0.341 |
 Atrial fibrillation | 16 (3.1%) | 30 (4.0%) | 1.298 | 0.700–2.407 | 0.448 |  |  |  | 2.149 | 1.035–4.463 | 0.053 |
 Acute kidney injury | 40 (8.4%) | 52 (7.5%) | 0.892 | 0.581–1.372 | 0.659 |  |  |  | 1.114 | 0.666–1.864 | 0.696 |
 Dialysis | 8 (2.0%) | 7 (1.3%) | 0.641 | 0.230–1.782 | 0.436 |  |  |  | 0.926 | 0.308–2.784 | > 0.999 |
 Wound infection | 19 (3.7%) | 55 (7.3%) | 2.064 | 1.210–3.521 | 0.007 |  |  |  | 2.430 | 1.331–4.434 | 0.004 |
 Repeated wound infection | 4 (0.8%) | 9 (1.2%) | 1.550 | 0.475–5.062 | 0.577 |  |  |  | 3.539 | 0.731–17.130 | 0.178 |
Long-term outcomes at 10Â years | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Cardiac death | 8 (5.4%) | 10 (3.5%) | 0.783 | 0.311–2.013 | 0.605 | 0.839 | 0.308–2.284 | 0.731 | 0.946 | 0.273–3.362 | 0.930 |
 Myocardial infarction | 6 (7.0%) | 8 (5.7%) | 0.783 | 0.273–2.302 | 0.650 | 0.938 | 0.320–0.750 | 0.906 | 1.274 | 0.404–4.114 | 0.679 |
 Repeat revascularization | 16 (16.9%) | 15 (10.2%) | 0.532 | 0.264–1.087 | 0.077 | 0.464 | 0.226–0.952 | 0.036 | 0.643 | 0.287–1.469 | 0.285 |
 MACE | 23 (20.3%) | 26 (13.5%) | 0.664 | 0.379–1.176 | 0.152 | 0.628 | 0.344–1.146 | 0.130 | 0.773 | 0.398–1.523 | 0.449 |
 Stroke | 14 (8.4%) | 27 (10.6%) | 1.245 | 0.652–2.409 | 0.506 | 1.416 | 0.730–2.747 | 0.303 | 1.668 | 0.815–3.468 | 0.161 |
Graft related outcomes at 10Â years | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 ITA graft failure†| 20 (8.9%) | 49 (20.1%) | 1.457 | 0.868–2.470 | 0.154 | 1.327 | 0.787–2.236 | 0.288 | 1.093 | 0.616–1.965 | 0.755 |
  FitzGibbon grade B | 1 (0.3%) | 8 (3.2%) | 4.760 | 0.605–38.872 | 0.138 | 4.760 | 0.594–38.130 | 0.142 | 3.135 | 0.376–27.187 | 0.291 |
  FitzGibbon grade O | 19 (8.7%) | 41 (17.5%) | 1.283 | 0.747–2.228 | 0.366 | 1.173 | 0.679–2.024 | 0.567 | 0.983 | 0.536–1.824 | 0.956 |
 LITA graft failure | 10 (3.6%) | 18 (7.3%) | 1.101 | 0.513–2.402 | 0.805 | 0.985 | 0.453–2.142 | 0.970 | 0.702 | 0.282–1.782 | 0.447 |
 RITA graft failure | 13 (6.7%) | 35 (14.9%) | 1.582 | 0.829–3.019 | 0.156 | 1.333 | 0.702–2.533 | 0.380 | 1.269 | 0.637–2.567 | 0.498 |